BioCentury
ARTICLE | Clinical News

Access Pharmaceuticals preclinical data

February 2, 2009 8:00 AM UTC

In mouse xenograft models of breast cancer, Angiolix significantly inhibited tumor growth. Additionally, the activity of the humanized IgG1k mAb that binds to Lactadherin was enhanced when given in c...